<DOC>
	<DOCNO>NCT02900053</DOCNO>
	<brief_summary>Post-Traumatic Stress Disorder ( PTSD ) anxiety disorder develop exposure terrify event ordeal potential actual occurrence grave physical harm . Traumatic event may trigger PTSD include violent personal assault , natural human-caused disaster , accident , military combat . People PTSD persistent frighten thought memory ordeal , may experience sleep problem , feel detach numb , easily startle . Its lifetime prevalence quite high , 7-8 % various study 4 % french study . The current PTSD treatment usually involve antidepressant serotonin-specific reuptake inhibitor ( SSRIs ) Cognitive Behavioral Therapies , exposure therapy trauma-linked element ( memory , feeling thought ) fear associate traumatic event decrease . But therapeutic response stay partial , even combine treatment . To improve PTSD treatment efficiency , innovative approach explore like new drug cerebral stimulation . This project aim assess efficacy less known promising therapeutic strategy PTSD : use transcranial Direct-Current Stimulation ( tDCS ) enhance trauma-focused therapy result .</brief_summary>
	<brief_title>Post-traumatic Stress Disorder Treatment Using Transcranial Direct Current Stimulation ( tDCS ) Enhancement Trauma-focused Therapy : Two-arm Randomized Controlled Multicentric Study .</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<criteria>Having chronic PTSD ( 3 month le 10 year ) without modification SSRI longterm treatment 4 week Between 18 65 yearsold Effective contraception woman , inability procreate medical surgical reason Able give write informed consent Affiliation social security system Not participate another study psychoactive substance Partiallysighted partially deaf person require equipment Person brain injury neurological disease ( epileptic , tumoral , vascular , degenerative ) , diagnose personal history recognize hereditary Addiction psychoactive substance last 6 month Any treatment could interact tDCS effect cortical reactivity ( citalopram , amphetamine , Ldopa , sulpiride , pergolide , lorazepam , rivastigmine , dextromethorphan NmethylDaspartate ( NMDA ) receptor antagonist , dcycloserine , carbamazepine , flunarizine , calcium channel blocker ) Pregnancy lactation Any intracephalic metallic material Person ca n't conform test instruction Person suffer bipolar disorder , chronic acute delusional disorder Any circumstance make person unable understand trial feature , purpose consequence</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>